Literature DB >> 16517877

Characteristics of Streptococcus pseudopneumoniae isolated from purulent sputum samples.

Elaine R Keith1, Roslyn G Podmore, Trevor P Anderson, David R Murdoch.   

Abstract

Streptococcus pseudopneumoniae is a recently described streptococcus that is phenotypically and genetically distinct from Streptococcus pneumoniae and other viridans streptococci. Key characteristics of S. pseudopneumoniae are the absence of a pneumococcal capsule, insolubility in bile, resistance or indeterminate susceptibility to optochin when incubated in 5% CO2 but susceptibility to optochin when incubated in ambient air, and a positive reaction with the AccuProbe DNA probe hybridization test. The clinical importance of this bacterium is currently unknown. We report the characteristics and associated clinical data of 35 strains of S. pseudopneumoniae isolated from sputum samples from 33 patients. All isolates produced a positive result with the NOW S. pneumoniae antigen test (Binax, Inc.). No isolate was resistant to penicillin, but 60% were resistant to erythromycin and 77% were resistant to tetracycline. All patients had lower respiratory tract symptoms, 79% had chronic obstructive pulmonary disease (COPD), and 33% had chest radiographic infiltrates. Compared with matched control patients who had Streptococcus pneumoniae isolated from sputum, patients with S. pseudopneumoniae infection were more likely to have a history of COPD (odds ratio [OR], 5.0; 95% confidence interval [CI], 1.67 to 20.11) or exacerbation of COPD (OR, 6.5; 95% CI, 2.61 to 16.20). Further research is needed to better characterize the epidemiology of S. pseudopneumoniae colonization and the role of S. pseudopneumoniae in COPD and other diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16517877      PMCID: PMC1393130          DOI: 10.1128/JCM.44.3.923-927.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Immunochromatographic test for rapid detection of Streptococcus pneumoniae in the nasopharynx.

Authors:  David R Murdoch; L Barth Reller
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 2.  Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?

Authors:  Sanjay Sethi
Journal:  Proc Am Thorac Soc       Date:  2004

3.  Validation of publication of new names and new combinations previously effectively published outside the IJSEM.

Authors: 
Journal:  Int J Syst Evol Microbiol       Date:  2005-01       Impact factor: 2.747

4.  Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I).

Authors:  Ileana Cochetti; Manuela Vecchi; Marina Mingoia; Emily Tili; Maria R Catania; Aldo Manzin; Pietro E Varaldo; Maria Pia Montanari
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: characterization of "Atypical" pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes.

Authors:  A M Whatmore; A Efstratiou; A P Pickerill; K Broughton; G Woodard; D Sturgeon; R George; C G Dowson
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Role of the major pneumococcal autolysin in the atypical response of a clinical isolate of Streptococcus pneumoniae.

Authors:  E Díaz; R López; J L García
Journal:  J Bacteriol       Date:  1992-09       Impact factor: 3.490

7.  Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov.

Authors:  Judy C Arbique; Claire Poyart; Patrick Trieu-Cuot; Gilles Quesne; Maria da Glória S Carvalho; Arnold G Steigerwalt; Roger E Morey; Delois Jackson; Ross J Davidson; Richard R Facklam
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia.

Authors:  David R Murdoch; Trevor P Anderson; Kirsten A Beynon; Alvin Chua; Angela M Fleming; Richard T R Laing; G Ian Town; Graham D Mills; Stephen T Chambers; Lance C Jennings
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Molecular peculiarities of the lytA gene isolated from clinical pneumococcal strains that are bile insoluble.

Authors:  Virginia Obregón; Pedro García; Ernesto García; Asunción Fenoll; Rubens López; José L García
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

10.  New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Nancy Evans; Brydon J B Grant; Timothy F Murphy
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

  10 in total
  31 in total

1.  Clinical and antimicrobial susceptibility data of 140 Streptococcus pseudopneumoniae isolates in France.

Authors:  C Laurens; A-L Michon; H Marchandin; J Bayette; M-N Didelot; H Jean-Pierre
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

2.  Evaluation of several biochemical and molecular techniques for identification of Streptococcus pneumoniae and Streptococcus pseudopneumoniae and their detection in respiratory samples.

Authors:  Els Wessels; Jacqueline J G Schelfaut; Alexandra T Bernards; Eric C J Claas
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

3.  Antimicrobial susceptibility profile of Streptococcus pseudopneumoniae isolated from sputum.

Authors:  Elaine R Keith; David R Murdoch
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

4.  Streptococcus pseudopneumoniae identification by pherotype: a method to assist understanding of a potentially emerging or overlooked pathogen.

Authors:  Marcus H Leung; Clare L Ling; Holly Ciesielczuk; Julianne Lockwood; Sarah Thurston; Bambos M Charalambous; Stephen H Gillespie
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

5.  Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR.

Authors:  L Selva; P Ciruela; C Esteva; M F de Sevilla; G Codina; S Hernandez; F Moraga; J J García-García; A Planes; F Coll; I Jordan; N Cardeñosa; J Batalla; L Salleras; A Dominguez; C Muñoz-Almagro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

6.  Late-onset bleb-related endophthalmitis caused by Streptococcus pseudopneumoniae.

Authors:  Hideaki Kawakami; Yuko Nakane; Hiroko Inuzuka; Tominori Fukagawa; Toshihiro Muto; Kiyofumi Mochizuki; Kiyofumi Ohkusu; Hiroyuki Suematsu; Yuka Yamagishi; Hiroshige Mikamo
Journal:  Int Ophthalmol       Date:  2013-07-25       Impact factor: 2.031

7.  Highly penicillin-resistant multidrug-resistant pneumococcus-like strains colonizing children in Oeiras, Portugal: genomic characteristics and implications for surveillance.

Authors:  Alexandra S Simões; Raquel Sá-Leão; Marc J Eleveld; Débora A Tavares; João A Carriço; Hester J Bootsma; Peter W M Hermans
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

8.  The development of a 16S rRNA gene based PCR for the identification of Streptococcus pneumoniae and comparison with four other species specific PCR assays.

Authors:  Nabil Abdullah El Aila; Stefan Emler; Tarja Kaijalainen; Thierry De Baere; Bart Saerens; Elife Alkan; Pieter Deschaght; Rita Verhelst; Mario Vaneechoutte
Journal:  BMC Infect Dis       Date:  2010-04-29       Impact factor: 3.090

9.  Cultivable internal bacterial flora of ticks isolated in Hungary.

Authors:  László Egyed; László Makrai
Journal:  Exp Appl Acarol       Date:  2013-12-24       Impact factor: 2.132

10.  Accuracy of phenotypic methods for identification of Streptococcus pneumoniae isolates included in surveillance programs.

Authors:  Sandra S Richter; Kristopher P Heilmann; Cassie L Dohrn; Fathollah Riahi; Susan E Beekmann; Gary V Doern
Journal:  J Clin Microbiol       Date:  2008-05-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.